Sedadex

Dechra Introduces Sedadex

7 years ago
3060 views

Posted
6th November, 2019 12h19

Author
Dechra

Dechra Veterinary Products has added the sedation and premedication product Sedadex® to its portfolio of anaesthesia and analgesia therapies.

Sedadex, which has the active ingredient dexmedetomidine, is indicated for sedation and analgesia and for premedication prior to general anaesthesia in dogs and cats. It comes in a 10 ml vial and has a 56-day broached shelf life.

Claire Morgan, Brand Manager from Dechra said: “Sedadex is a highly selective α2 adrenoceptor agonist that is licensed for intravenous or intramuscular use in dogs and intramuscular injection in cats.

“It is a welcome addition to Dechra’s anaesthesia and analgesia range and compliments our existing therapies that include Comfortan®, Sedator® and Atipam®”

For more information, go to www.dechra.co.uk

More from Dechra

• Despite spotlight on equine ‘flu, strangles cases continue to rise
• DuOtic otic gel for otitis externa now available
• Dechra launches new and improved kidney disease diets
• New studies demonstrate the benefits of Strangvac vaccination during strangles outbreaks
• Dechra Academy launches new Not One More Vet modules